Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (1,834,686)	$ (6,616,541)	$ (2,469,594)	$ (2,612,353)	$ (8,451,227)	$ (5,081,947)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense					228,080	233,646
Depreciation expense	6,262		642		12,524	4,449
Non-cash lease expense					14,960	23,391
Changes in operating assets and liabilities:
Prepaid expenses and other current assets					66,695	(1,556,399)
Accounts payable					(285,855)	41,146
Accrued expenses					(145,856)	377,057
Operating lease liability					(16,752)	(18,349)
Accrued interest on Promissory Notes Payable & Convertible Note					36,920
Net cash used in operating activities					(8,540,511)	(5,977,006)
Cash flows from investing activities:
Purchase of property and equipment						(148,116)
Net cash used in investing activities						(148,116)
Cash flows from financing activities:
Proceeds from the Convertible Note					2,500,000
Repayment of the Convertible Note					(2,500,000)
Proceeds from the Business Combination, net of issuance costs					11,923,499
Proceeds from the PIPE Investment, net of issuance costs					7,262,219
Repurchase for the Forward Share Purchase Agreement exercise		(7,652,325)			(7,652,325)
Repayments of Promissory Notes Payable, including interest expense					(796,882)
Proceeds from issuance of common stock, net of issuance costs						599,996	$ 6,100,000
Net cash provided by financing activities					10,741,598	8,004,865
Net (decrease) increase in cash and cash equivalents					2,201,087	1,879,743
Cash and cash equivalents at beginning of period		$ 1,274,729		$ 4,492,400	1,274,729	4,492,400
Cash and cash equivalents at end of period	$ 3,475,816		$ 6,372,143		3,475,816	6,372,143	$ 4,492,400
Supplemental disclosure of non-cash investing and financing activities:
Current liabilities assumed in the Business Combination					2,149,432
Deferred underwriting commissions assumed in the Business Combination					2,911,260
Equity Issuance for fees in connection with the Business Combination					300
Issuance of Common Warrants in connection with the PIPE Investment					3,634,262
Issuance of Placement Agent Warrants in connection with the PIPE Investment					508,797
Premium Financing Agreement					513,333
Acquisition of right-of-use asset through operating lease obligation						67,344
Issuance of warrants in connection with Series A-1 Preferred Stock						326,675
Rollover Warrants [Member]
Cash flows from financing activities:
Proceeds from Warrant exercise					5,074
Pre-Funded Warrants [Member]
Cash flows from financing activities:
Proceeds from Warrant exercise					13
Series A Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Preferred Stock, net of issuance costs						3,499,997
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Series A Preferred Stock to common stock					3,903,730
Series A-1 Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Preferred Stock, net of issuance costs						$ 3,904,872
Supplemental disclosure of non-cash investing and financing activities:
Conversion of Series A Preferred Stock to common stock					$ 3,578,197